[RDHL] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
25-Jul-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -40.72%
YoY- -73.43%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 20,943 1,401 2,206 1,523 0 1 4 316.16%
PBT -18,638 -9,835 -10,083 -15,512 -8,944 -3,292 -4,236 27.98%
Tax 42 170 133 150 109 1,420 1,146 -42.33%
NP -18,638 -9,835 -10,083 -15,512 -8,944 -3,292 -4,236 27.98%
Tax Rate - - - - - - - -
Total Cost 39,581 11,236 12,289 17,035 8,944 3,293 4,240 45.05%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -88.99 -702.00 -457.07 -1,018.52 0.00 -329,200.00 -105,900.00 -69.24%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -19.99 -13.87 -17.17 -36.14 -28.07 -10.74 -19.28 0.60%
EPS Diluted -19.99 -13.87 -17.17 -36.14 -28.07 -10.66 -19.10 0.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.